Serum mesothelin may be a useful test to monitor treatment response in mesothelin-expressing cancers, because after surgery there is a rapid decrease in mesothelin levels in patients with peritoneal mesothelioma. The gene discussed is MSLN; the disease is peritoneal mesothelioma.